Novel Blood Purification System for Regulating Excessive Immune Reactions in Severe Sepsis and Septic Shock: An Ex Vivo Pilot Study

Therapeutic Apheresis and Dialysis

Volumn 19, Issue 4, 2015, Pages 308-315

  Hara, Yoshitaka ^a   Shimomura, Yasuyo ^a   Nakamura, Tomoyuki ^a   Kuriyama, Naohide ^a   Yamashita, Chizuru ^a   Kato, Yu ^a   Miyasho, Taku ^b   Sakai, Toshikazu ^a   Yamada, Shingo ^c   Moriyama, Kazuhiro ^a   Nishida, Osamu ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

^c SHINO TEST CORPORATION   (Japan)

Author keywords

Blood purification; Cytokine; Granulocyte; Immunomodulation; Sepsis

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; IL10 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIALYSIS PUMP; EX VIVO STUDY; FEMALE; GRANULOCYTE; IMMUNOMODULATION; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PIG; PILOT STUDY; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; ADSORPTION; ANIMAL; BLOOD; CELLULAR IMMUNITY; DEVICES; DISEASE MODEL; HEMODIAFILTRATION; IMMUNOLOGY; LEUKOCYTE COUNT; PHYSIOLOGY; PROCEDURES; SHOCK, SEPTIC;

ADSORPTION; ANIMALS; DISEASE MODELS, ANIMAL; HEMODIAFILTRATION; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-8; LEUKOCYTE COUNT; PILOT PROJECTS; SEPSIS; SHOCK, SEPTIC; SWINE;

EID: 84941907184     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12338     Document Type: Article

References (9)

1. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007;5:577-582.
2. Urban C, Zychlinsky A. Netting bacteria in sepsis. Nat Med 2007;13:403-404.
3. Nishida O, Nakamura T, Kuriyama N etal. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. Contrib Nephrol 2011;173:172-181.
4. Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils. Ther Apher Dial 2006;10:247-256.
5. Yumoto M, Nishida O, Moriyama K etal. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial 2011;15:385-393.
6. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res 2004;53:277-283.
7. Takenaka Y. Granulocyte and monocyte apheresis therapy using the adacolumn. Jpn J Apher 2003;22:18-26 (in Japanese).
8. Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-141.
9. Tanaka S, Kashiwagi N, Adachi M, Asao T, Nagamachi Y. Efficacy of extracorporeal granulotrap column (G-1 column) in rabbit endotoxin shock models. Kita Kanto Igaku 1997;47:393-398.